Pharmaceutical

Moderna mpox mRNA vaccine shows early promise in monkey study

Moderna is currently running a Phase I/II trial of the mRNA mpox vaccine mRNA-1769 in healthy participants.

Sep 6, 2024 - 04:00
Moderna mpox mRNA vaccine shows early promise in monkey study
Moderna is currently running a Phase I/II trial of the mRNA mpox vaccine mRNA-1769 in healthy participants.
Read the original article

Tags:

Previous Article

Lilly partners with Haya for lncRNA obesity target deal worth $1bn

Next Article

eGenesis scoops $191m for genetically modified pig kidney transplant trial

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Cipla and Glenmark initiate recall of certain products in the US

Cipla and Glenmark initiate recall of certain products ...

May 7, 2024

Vertex licenses Editas’ gene editing technology in $100m deal

Vertex licenses Editas’ gene editing technology in $100...

Dec 14, 2023

Key House Democrat demands NIH answer for pace of long Covid research

Key House Democrat demands NIH answer for pace of long ...

May 11, 2023